| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(98)00306-0 |
| P698 | PubMed publication ID | 9622667 |
| P2093 | author name string | T Yamamoto | |
| Y Sakashita | |||
| P2860 | cites work | A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 |
| A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. | Q33510083 | ||
| A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
| Antagonists of neuronal calcium channels: structure, function, and therapeutic implications | Q39479175 | ||
| Effects of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, and N-methyl-D-aspartate receptor antagonists on the thermal hyperalgesia induced by partial sciatic nerve injury in the rat. | Q44347263 | ||
| Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists | Q46025693 | ||
| Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. | Q46709876 | ||
| Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats | Q46978379 | ||
| Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
| Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurones produced by subcutaneous formalin inflammation. | Q51552875 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | voltage | Q25428 |
| P304 | page(s) | 329-332 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. | |
| P478 | volume | 794 |
| Q48242206 | A basic bifurcation structure from bursting to spiking of injured nerve fibers in a two-dimensional parameter space |
| Q34075138 | An evaluation of intrathecal ziconotide for the treatment of chronic pain |
| Q34515732 | Analgesic effect of highly reversible ω-conotoxin FVIA on N type Ca2+ channels |
| Q30249165 | Animal models of chronic pain: Advances and challenges for clinical translation |
| Q41835834 | Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain |
| Q37819805 | Calcium channel functions in pain processing |
| Q73451199 | Conopeptides: From deadly venoms to novel therapeutics |
| Q57031032 | Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats |
| Q42556628 | Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain |
| Q41902234 | Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociception |
| Q49372721 | Effect of the spider toxin Tx3-3 on spinal processing of sensory information in naive and neuropathic rats: an in vivo electrophysiological study. |
| Q74014783 | Effects of pre-emptively administered nociceptin on the development of thermal hyperalgesia induced by two models of experimental mononeuropathy in the rat |
| Q46083475 | Emerging drugs for neuropathic pain |
| Q37855928 | Evolving therapeutic indications for N-type calcium channel blockers: from chronic pain to alcohol abuse |
| Q39504921 | Gabapentin evoked changes in functional activity in nociceptive regions in the brain of the anaesthetized rat: an fMRI study |
| Q37396872 | Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression |
| Q26823531 | Ionotropic glutamate receptors and voltage-gated Ca²⁺ channels in long-term potentiation of spinal dorsal horn synapses and pain hypersensitivity |
| Q34212776 | Pains, gains, and midbrains |
| Q34185102 | Pharmacologic treatment of neuropathic pain |
| Q37362037 | Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief |
| Q44589954 | Reversal of experimental neuropathic pain by T-type calcium channel blockers |
| Q37327356 | Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model. |
| Q36016825 | Spontaneous Chronic Pain After Experimental Thoracotomy Revealed by Conditioned Place Preference: Morphine Differentiates Tactile Evoked Pain From Spontaneous Pain |
| Q38020929 | Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain |
| Q36277918 | Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain |
| Q24658327 | Ziconotide: a review of its pharmacology and use in the treatment of pain |
| Q36286186 | Ziconotide: can we use it in palliative care? |
| Q45805613 | ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential |
Search more.